Tiffany Mauldin
Family Medicine · Pearland, TXNPI 1376019752
Payments from drug & device makers
Across 220 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$593
- Novo Nordisk$419
- AbbVie$327
- GSK$304
- Amarin Pharma, Inc.$289
- Sanofi-aventis U.S. LLC$164
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,011100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 36 | $593 |
| Novo Nordisk | 26 | $419 |
| AbbVie | 19 | $327 |
| GSK | 17 | $304 |
| Amarin Pharma, Inc. | 20 | $289 |
| Sanofi-aventis U.S. LLC | 10 | $164 |
| AstraZeneca | 11 | $162 |
| Inspire Medical Systems, Inc. | 3 | $154 |
| Boehringer Ingelheim | 10 | $152 |
| Axogen | 1 | $139 |
| Novartis | 6 | $111 |
| Exact Sciences | 7 | $108 |
| Esperion Therapeutics, Inc. | 6 | $107 |
| Boston Scientific | 4 | $83 |
| Astellas Pharma US Inc | 3 | $73 |
| Abiomed | 2 | $63 |
| Eisai Inc. | 2 | $61 |
| Amgen | 4 | $55 |
| Johnson & Johnson | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $49 |
| Medtronic | 2 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Bayer | 2 | $35 |
| Imperative Care, Inc | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Merck | 2 | $24 |
| Ironwood Pharmaceuticals, Inc | 1 | $24 |
| Abbott | 1 | $22 |
| Halozyme Inc | 1 | $22 |
| Pfizer | 1 | $22 |
| 3b Medical, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Pulmonx Corporation | 1 | $16 |
| Philips North America LLC | 1 | $15 |
How this compares
$4,011 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 56 | $70,299 |
| OzempicSemaglutide | 52 | $52,607 |
| MounjaroTirzepatide | 25 | $27,056 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $24,314 |
| TrulicityDulaglutide | 14 | $21,421 |
| EliquisApixaban | 24 | $18,273 |
| XareltoRivaroxaban | 21 | $16,418 |
| LinzessLinaclotide | 11 | $10,203 |
| PremarinEstrogens, Conjugated | 12 | $3,865 |
| Rosuvastatin Calcium | 121 | $1,386 |
| Losartan Potassium | 109 | $1,293 |
| Omeprazole | 98 | $1,240 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,238 |
| ValacyclovirValacyclovir Hcl | 18 | $1,191 |
| Atorvastatin Calcium | 148 | $1,183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $152 | $70,29956 claims |
| Novo NordiskOzempic | $419 | $52,60752 claims |
| Lilly USA, LLCMounjaro, Trulicity | $593 | $48,47639 claims |
| GSKTrelegy Ellipta | $304 | $24,31426 claims |
| PfizerEliquis, Premarin | $22 | $22,13836 claims |
| Johnson & JohnsonXarelto | $51 | $16,41821 claims |
| AbbVieLinzess | $327 | $10,20311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Pearland
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.